Frederick L. Hall
Chief Executive Officer at GenVivo, Inc.
Profile
Frederick L.
Hall co-founded Epeius Biotechnologies Corp.
in 2000 and currently serves as President, Chief Executive Officer, and Chief Scientific Officer.
Prior to co-founding Epeius Biotechnologies, he was Director of Research in the Departments of Orthopaedic Surgery, Cardiothoracic Surgery, and Colorectal Surgery, and Associate Professor of Molecular Pharmacology and Toxicology at the University of Southern California School of Pharmacy.
Dr. Hall received a Bachelor's degree in Biology from the University of Colorado and a PhD in Physiology and Biophysics from Colorado State University.
Frederick L. Hall active positions
| Companies | Position | Start |
|---|---|---|
GenVivo, Inc.
 GenVivo, Inc. BiotechnologyHealth Technology GenVivo, Inc. develops targeted delivery system that transports genes directly to diseased areas in the body. Its products are used for the treatment of metastatic cancer. The company was founded in 2000 by Erlinda Maria Gordon and Frederick L. Hall and is headquartered in San Marino, CA. | Chief Executive Officer | 1999-12-31 |
Training of Frederick L. Hall
| The University of Colorado | Undergraduate Degree |
| Colorado State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
GenVivo, Inc.
GenVivo, Inc. BiotechnologyHealth Technology GenVivo, Inc. develops targeted delivery system that transports genes directly to diseased areas in the body. Its products are used for the treatment of metastatic cancer. The company was founded in 2000 by Erlinda Maria Gordon and Frederick L. Hall and is headquartered in San Marino, CA. | Health Technology |
- Stock Market
- Insiders
- Frederick L. Hall
